NDAORALTABLETPriority Review
Approved
Dec 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
9
Mechanism of Action
selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. In animal models, LIPITOR lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA…
Indications (1)
Clinical Trials (5)
Actual Use Trial of Atorvastatin Calcium 10 mg
Started Oct 2013
1,311 enrolled
Hypercholesterolemia
Special Drug Use-Results Survey of Lipitor Tablets
Started Sep 2010
24,050 enrolled
Hypercholesterolemia
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
Started Mar 2010
500 enrolled
Medication Non-Adherence
Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study
Started Oct 2007
425 enrolled
Dyslipidemias
Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.
Started Nov 2004
900 enrolled
Hyperlipidemia